0001609351-17-000061.txt : 20170621 0001609351-17-000061.hdr.sgml : 20170621 20170621164411 ACCESSION NUMBER: 0001609351-17-000061 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170619 FILED AS OF DATE: 20170621 DATE AS OF CHANGE: 20170621 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Spark Therapeutics, Inc. CENTRAL INDEX KEY: 0001609351 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 462654405 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3737 MARKET STREET STREET 2: SUITE 1300 CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: 888-772-7560 MAIL ADDRESS: STREET 1: 3737 MARKET STREET STREET 2: SUITE 1300 CITY: PHILADELPHIA STATE: PA ZIP: 19104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: High Katherine A CENTRAL INDEX KEY: 0001631248 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36819 FILM NUMBER: 17923276 MAIL ADDRESS: STREET 1: 3737 MARKET STREET STREET 2: SUITE 1300 CITY: PHILADELPHIA STATE: PA ZIP: 19104 4 1 wf-form4_149807783601601.xml FORM 4 X0306 4 2017-06-19 0 0001609351 Spark Therapeutics, Inc. ONCE 0001631248 High Katherine A C/O SPARK THERAPEUTICS, INC. 3737 MARKET STREET, SUITE 1300 PHILADELPHIA PA 19104 1 1 0 0 See Remarks Common Stock 2017-06-19 4 M 0 10000 3.45 A 220000 D Common Stock 2017-06-19 4 S 0 10000 60 D 210000 D Stock Option (right to buy) 3.45 2017-06-19 4 M 0 10000 0 D 2024-07-02 Common Stock 10000.0 118249 D The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2017. This option was granted on July 2, 2014 and vests over four years, with 25% of the shares underlying the option vesting on May 24, 2015, and the remainder vesting quarterly thereafter. President and Chief Scientific Officer /s/ Joseph W. La Barge, attorney-in-fact for Katherine A. High 2017-06-21